|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
15 to 69
|
|
|
|
|
|
|
|
CRC-TU-HO3001 EU-93029
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 79
|
|
|
|
|
|
|
|
EORTC-06942
|
|
|
|
|
|
|
|
Last Modified: 5/21/2007  First Published: 9/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Not specified
|
|
|
|
|
|
|
|
MRC-UKLG-LY09 EU-98020, NCT00003421
|
|
|
|
|
|
|
|
Last Modified: 5/31/2007  First Published: 1/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
16 and over
|
|
|
|
|
|
|
|
BNLI-LY03 EU-98040, NCT00003617
|
|
|
|
|
|
|
|
Last Modified: 5/31/2007  First Published: 12/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
15 to 70
|
|
|
|
|
|
|
|
SNLG-NHL-VIII EU-98034, NCT00003639
|
|
|
|
|
|
|
|
Last Modified: 11/20/2008  First Published: 2/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Not specified
|
|
|
|
Other
|
|
|
|
LRF-CLL4 LRG-MRC-LEUK-CLL4, EU-99030, MRC-LEUK-CLL4, NCT00004218, EUDRACT-58585610, ISRCTN58585610
|
|
|
|
|
|
|
|
Last Modified: 1/4/2008  First Published: 9/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 70
|
|
|
|
Other
|
|
|
|
BNLI-MCD/FMD EU-20035, NCT00006250
|
|
|
|
|
|
|
|
Last Modified: 6/10/2004  First Published: 6/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 75
|
|
|
|
Other
|
|
|
|
EORTC-06992-CLL-3 NCT00017108
|
|
|
|
|
|
|
|
Last Modified: 11/10/2006  First Published: 1/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
CKVO-2001-01 HOVON-47NHL, EU-20131, HOVON-CKTO-2001-01, EORTC-20013, NCT00028691
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
no age specified
|
|
|
|
NCI
|
|
|
|
SWOG-7436
|
|
|
|